Salif Bio Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Corporate
- Financing Rounds
-
3
Salif Bio General Information
Description
Developer of regenerative medicine products designed for endogenous regeneration of the extracellular matrix. The company's technology utilizes cell-free mediated regeneration, human-derived acellular adipose matrix platforms, recombinant fusion protein platforms, clinical-grade tissue resource banks, and modular protein modification, enabling medical institutions to achieve physiological tissue reconstruction and long-lasting soft tissue repair.
Contact Information
Corporate Office
- Room 210, Building 2
- Number 68 Jiangchuan East Road, Minhang District
- Shanghai, 200001
- China
Corporate Office
- Room 210, Building 2
- Number 68 Jiangchuan East Road, Minhang District
- Shanghai, 200001
- China
Salif Bio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Salif Bio Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Salif Bio FAQs
-
When was Salif Bio founded?
Salif Bio was founded in 2020.
-
Where is Salif Bio headquartered?
Salif Bio is headquartered in Shanghai, China.
-
What industry is Salif Bio in?
Salif Bio’s primary industry is Therapeutic Devices.
-
Is Salif Bio a private or public company?
Salif Bio is a Private company.
-
What is Salif Bio’s current revenue?
The current revenue for Salif Bio is .
-
Who are Salif Bio’s investors?
Jenkem Technology and EverCare (China) have invested in Salif Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
